Vaccines, global health and social equity

Immunology and Cell Biology

Volumn 87, Issue 4, 2009, Pages 274-278

  Levine, Myron M ^a   Robins Browne, Roy ^b,c  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c ROYAL CHILDREN'S HOSPITAL   (Australia)

Author keywords

Immunization; Infant mortality; Vaccines

Indexed keywords

HAEMOPHILUS INFLUENZAE TYPE B VACCINE; HEPATITIS B VACCINE; PNEUMOCOCCUS VACCINE; VACCINE; WART VIRUS VACCINE;

CHILDHOOD DISEASE; CHILDHOOD MORTALITY; DEVELOPING COUNTRY; DRUG COST; HAEMOPHILUS INFECTION; HEALTH BEHAVIOR; HEALTH CARE ACCESS; HEALTH CARE COST; HEALTH CARE NEED; HEALTH CARE POLICY; HEALTH CARE QUALITY; HUMAN; INFANT MORTALITY; REVIEW; SOCIAL JUSTICE; STREPTOCOCCUS PNEUMONIA; VACCINATION; VACCINE PRODUCTION;

DEVELOPING COUNTRIES; HUMANS; IMMUNIZATION PROGRAMS; INFANT; INFANT MORTALITY; INFANT, NEWBORN; POVERTY; PUBLIC HEALTH; SOCIOECONOMIC FACTORS; VACCINATION; VACCINES; WORLD HEALTH;

EID: 67349119191     PISSN: 08189641     EISSN: 14401711     Source Type: Journal    
DOI: 10.1038/icb.2009.15     Document Type: Review

References (32)

1. Moccia P (ed). State of the World's Children 2009. Maternal and Newborn Health. UNICEF: New York, 2008.
2. Black RE, Morris SS, Bryce J. Where and why are million children dying every year? Lancet 2003; 361: 22 26- 2 234.
3. UNICEF. State of the World's Children 20Child Survival. Hatteras Press: New York, 2007, 1-154.
4. Wegman ME. Infant mortality in the 20th century, dramatic but uneven progress. JNutr 2001; 131: 401S-408S.
5. Bryce J, Boschi-Pinto C, Shibuya K, Black RE. WHO estimates of the causes of death in children. Lancet 2005; 365: 1147-115 2.
6. Lee K-S. Infant mortality decline in the late 19th and early 20th centuries. Perspect Biol Med 2007; 50: 585-60 2.
7. Weekly Reports of the Department of Health. New York City. New York City, 193 2, p396.
8. McDermott W. Environmental factors bearing on medical education in the developing countries. A. Modern medicine and the demographic-disease pattern of overly traditional societies: a technologic misfit. JMed Educ 1966; (Suppl): 137-16 2.
9. Meyer EC, Infant Mortality in New York City. A Study of the Results Accomplished by Infant-Life Saving Agencies. The Rockefeller Foundation International Health Board:New York City, 19 21, 1-135
10. Stern A. Infant mortality in summer: howto conduct a successful campaign against it. Arch Pediatr 1911; 28: 287- 294.
11. Williams LR, Arnstein L, Emerson H, Folks H, Huddleston JH, ParkWH et al. Flies and Diarrheal Disease. The New York Association for Improving the Condition of the Poor and the Bureau of Public Health and Hygiene, Departmentof Social Welfare: NewYork, 1914, 1- 29.
12. Cutts FT, Zaman SMA, Enwere G, Jaffar S, Levine OS, Okoko JB et al. Efficacy of nine- valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococ- cal disease in the Gambia: randomised, double-blind, placebo-controlled trial. Lancet 2005, 1139-1146.
13. Klugman KP, Madhi SA, Huebner RE, Kohberger R, Mbelle N, Pierce N. A trial of a 9-valent pneumococcal conjugate vaccine in children with and those without HIV infection. NEnglJMed 2003; 349: 1341-1348.
14. Mulholland K, Hilton S, Adegbola R, Usen S, Oparaugo A, Omosigho C et al. Randomised trial of Haemophilus influenzae type-b tetanus protein conjugate for prevention of pneumonia and meningitis in Gambian infants. Lancet 1997; 349:1191-1197.
15. Levine OS, Lagos R, Munoz A, Villaroel J, Alvarez AM, Abrego P et al. Defining the burden of pneumonia in children preventable by vaccination against Haemophilus influenzae type b. Pediatr Infect Dis J 1999; 18: 1060-1064.
16. Lagos R, Horwitz I, Toro J, San Martin O, Abrego P, Bustamante C et al. Large scale, postlicensure, selective vaccination of Chilean infants with PRP-T conjugate vaccine: practicality and effectiveness in preventing invasive Haemophilus influenzae type b infections. Pediatr Infect Dis J 1996; 15: 216- 2 2 2.
17. Adegbola RA, Secka O, Lahai G, Lloyd-Evans N, Njie A, Usen S et al. Elimination of Haemophilus influenzae type b (Hib) disease from the Gambia after the introduction of routine immunisation with a Hib conjugate vaccine: a prospective study. Lancet 2005; 366:144-150.
18. Cowgill KD, Ndiritu M, Nyiro J, Slack MP, Chiphatsi S, Ismail A et al. Effectiveness of Haemophilus influenzae type b conjugate vaccine introduction into routine childhood immunization in Kenya. JAMA 2006; 296: 671-678.
19. Lewis RF, Kisakye A, Gessner BD, Duku C, Odipio JB, Iriso R et al. Action for child survival: elimination of Haemophilus influenzae type b meningitis in Uganda. Bull World Health Organ 2008; 86: 29 2-301.
20. Sow SO, Tapia MD, Diallo S, Keita MM, Sylla M, Onwuchekwa U et al. Haemophilus influenzae type b conjugate vaccine introduction in Mali: impact on disease burden and serologic correlate of protection. Am J Trop Med Hyg 20(in press).
21. Levine MM, Campbell JD, Kotloff KL. Overviewof vaccines and immunisation. BrMed Bull 2002; 62: 1-13.
22. Henderson DA. Smallpox eradication. Public Health Rep 1980; 95: 4 2 2-4 26.
23. Dutta A. Epidemiology of poliomyelitis-options and update. Vaccine 2008; 26: 5767-5773.
24. AdvisoryCommittee on Poliomyelitis Eradication. Conclusions and recommendations of the Advisory Committee on Poliomyelitis Eradication, November 2008. Wkly Epidemiol Rec 2009; 84:17- 28.
25. World Health Organization. Progress in global measles control and mortality reduction, 2000- 2006. WklyEpidemiol Rec 2007; 82: 418-4 24.
26. Hersh BS, Tambini G, Nogueira AC, Carrasco P, De Quadros CA. Review of regional measles surveillance data in the Americas, 1996-99. Lancet 2000; 355: 1943-1948.
27. Adegbola RA, Usen SO, Weber M, Lloyd-Evans N, Jobe K, Mulholland K et al. Haemophilus influenzae type b meningitis in the Gambia after introduction of a conjugate vaccine. Lancet 1999; 354: 1091-109 2.
28. Henderson RH, Keja J, Hayden G, Galazka A, Clements J, Chan C. Immunizing the children of the world: progress and prospects. Bull World Health Organ 1988; 66: 535-543.
29. Cutts FT. Advances and challenges for the Expanded Programme on Immunization. Br Med Bull 1998; 54: 445-461.
30. Levine OS, O'Brien KL, Knoll M, Adegbola RA, BlackS, Cherian Tet al. Pneumococcal vaccination in developing countries. Lancet 2006; 367: 1880-188 2.
31. Levine MM. Can needle-free administration of vaccines become the norm in global immunization? Nat Med 2003; 9: 99-103.
32. Vandelaer J, Bilous J, Nshimirimana D. Reaching Every District (RED) approach: a way to improve immunization performance. Bull World Health Organ 2008; 86:A-B.